Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 9, 2026 · Leadership change · Financial statements
CVRx, Inc.
8
Leadership change
Jun 9, 2026
| Item 5.02 | Director or executive officer departure or appointment |
| Item 9.01 | Financial statements and exhibits |
CVRx, Inc. filed this to disclose a change in directors or executive officers: appointments, departures, or role changes that can signal a strategic shift.
1 CVRx Announces Chief Financial Officer Transition MINNEAPOLIS, June 9, 2026 (GLOBE NEWSWIRE) CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that Jared Oasheim, the Company’s Chief Financial Officer, will be stepping down from his role to pursue other professional opportunities.
This filing reports Item 5.02 (director or executive officer departure or appointment). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
CVRx, Inc. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
